Seven lobbyists and executives who work with top pharmaceutical and biotech companies told Reuters they are pushing to delay ...

My sister, who is a lifelong Democrat, wanted to school me on everything from the "real" causes of inflation - the pandemic, ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Shares of Eli Lilly LLY and Novo Nordisk NVO were up on Tuesday, likely due to a proposal by President Biden that Medicare ...

Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...

The Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...

“The benefits [of the drugs] are substantial,” said Justice, who also said that he is taking Ozempic to lose weight ...

The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for people seeking obesity treatment.The new rule, which was proposed by the administration ...

The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

The White House said it's moving to make the federal health insurance plans pay for anti-obesity drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound for people who are obese, even if they don ...